Catalyst Funds Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
14,002
+10,152
+264% +$819K 0.07% 267
2026
Q1
$272K Buy
+3,850
New +$288K 0.05% 383
2025
Q3
– Sell
-5,800
Closed -$466K – 591
2025
Q2
$466K Buy
+5,800
New +$448K 0.13% 214
2025
Q1
– Sell
-5,400
Closed -$442K – 537
2024
Q4
$442K Sell
5,400
-900
-14% -$74.9K 0.11% 168
2024
Q3
$520K Sell
6,300
-300
-5% -$22.4K 0.11% 130
2024
Q2
$463K Buy
+6,600
New +$471K 0.12% 112

Other funds holding MET

Catalyst Funds Management's MET Position: Q2 2026 in Review

Catalyst Funds Management increased its MetLife (MET) stake by 264% in Q2 2026, buying an estimated $819K and bringing the position to 14,002 shares worth $1.18M. The position accounts for 0.07% of the portfolio, ranked #267.

Catalyst Funds Management first reported a position in MET in Q2 2024 and has held it in 6 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Catalyst Funds Management held 14,002 shares of MetLife worth $1.18M as of Q2 2026.
  • Catalyst Funds Management bought 10,152 MetLife shares in Q2 2026, an estimated $819K.
  • MetLife made up 0.07% of Catalyst Funds Management's portfolio in Q2 2026, its #267 holding.
  • Catalyst Funds Management first reported a position in MetLife in Q2 2024 and has held it in 6 quarters since.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.